Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population–based cohort study

BACKGROUND: Allopurinol is commonly prescribed for gout, and its clinical use may expand with ongoing trials assessing its potential cardiorenal benefits. Because heart disease has been suggested to be a risk factor for allopurinol-associated severe cutaneous adverse reactions, we sought to confirm...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:CMAJ
Glavni autori: Yokose, Chio, Lu, Na, Xie, Hui, Li, Lingyi, Zheng, Yufei, McCormick, Natalie, Rai, Sharan K., Aviña-Zubieta, J. Antonio, Choi, Hyon K.
Format: Artigo
Jezik:Inglês
Izdano: Joule Inc. 2019
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6773546/
https://ncbi.nlm.nih.gov/pubmed/31570545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.190339
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items